
After six people who received the Johnson & Johnson one-dose COVID-19 vaccine developed a type of rare and severe blood clot, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention on Tuesday each said they will seek a “pause” in use of the shots as they review the data. The… read on > read on >